ARS Pharmaceuticals, Inc. (BOATS:SPRY) IPO
IPO
Went public as Silverback Therapeutics, Inc. Priced at US$21.00 a share on Dec 3, 2020.
- Price
- US$21.00 a share
- Shares offered
- 11,500,000 shares of common stock
- Offering size
- US$241.5 million
- Underwriters' option
- Up to 1,725,000 more shares
- Underwriters
- Goldman Sachs & Co. LLC, SVB Leerink, Stifel, H.C. Wainwright & Co. · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 2, 2020 |
| Filed publicly | Nov 10, 2020 |
| Amended twice | Newest Dec 3, 2020 |
| Shares registered with an exchange | Dec 1, 2020 |
| Declared effective by the SEC | Dec 3, 2020 |
| Final prospectus, with the price | Dec 4, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Dec 4, 2020 |
| EFFECT · Notice that a registration is effective | Dec 3, 2020 |
| S-1MEF · Registration of more shares for the same offering | Dec 3, 2020 |
| CERT · Exchange's certificate of listing | Dec 3, 2020 |
| S-1/A · Registration statement, amended | Dec 3, 2020 |
| CORRESP · Letter to the SEC | Dec 1, 2020 |
| CORRESP · Letter to the SEC | Dec 1, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 1, 2020 |
| CORRESP · Letter to the SEC | Nov 30, 2020 |
| S-1/A · Registration statement, amended | Nov 30, 2020 |
| UPLOAD · Letter from the SEC | Nov 27, 2020 |
| CORRESP · Letter to the SEC | Nov 18, 2020 |
| CORRESP · Letter to the SEC | Nov 10, 2020 |
| S-1 · Registration statement | Nov 10, 2020 |
| UPLOAD · Letter from the SEC | Oct 29, 2020 |
| DRS · Draft registration statement | Oct 2, 2020 |
From the cover of the final prospectus (424B4) filed Dec 4, 2020